Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Sleep and Breathing
Erschienen in: Sleep and Breathing 3/2017

11.01.2017 | Sleep Breathing Physiology and Disorders • Original Article

The role of the Nox4-derived ROS-mediated RhoA/Rho kinase pathway in rat hypertension induced by chronic intermittent hypoxia

verfasst von: Wen Lu, Jing Kang, Ke Hu, Si Tang, Xiufang Zhou, Lifang Xu, Yuanyuan Li, Shuhui Yu

Erschienen in: Sleep and Breathing | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Obstructive sleep apnea syndrome, which is a risk factor for resistant hypertension, is characterized by chronic intermittent hypoxia (CIH) and is associated with many cardiovascular diseases. CIH elicits systemic oxidative stress and sympathetic hyperactivity, which lead to hypertension. Rho kinases (ROCKs) are considered to be major effectors of the small GTPase RhoA and have been extensively studied in the cardiovascular field. Upregulation of the RhoA/ROCK signaling cascade is observed in various cardiovascular disorders, such as atherosclerosis, pulmonary hypertension, and stroke. However, the exact molecular function of RhoA/ROCK in CIH remains unclear and requires further study.

Objective

This study aimed to investigate the role of the NADPH oxidase 4 (Nox4)-induced ROS/RhoA/ROCK pathway in CIH-induced hypertension in rats.

Methods

Male Sprague–Dawley rats were exposed to CIH for 21 days (intermittent hypoxia of 21% O2 for 60 s and 5% O2 for 30 s, cyclically repeated for 8 h/day). We randomly assigned 56 male rats to groups of normoxia (RA) or vertically implemented CIH together with vehicle (CIH-V), GKT137831 (CIH-G), N-acetyl cysteine (NAC) (CIH-N), or Y27632 (CIH-Y). The rats in the RA group were continuously exposed to room air, whereas the rats in the other groups were exposed to CIH. Systolic blood pressure (BP) was monitored at the beginning of each week. After the experiment, renal sympathetic nerve activity (RSNA) was recorded, and serum and renal tissues were subjected to molecular biological and biochemical analyses.

Results

Compared with the BP of RA rats, the BP of CIH-V rats started to increase 2 weeks after the beginning of the experiment, subsequently stabilizing at a high level at the end of the third week. CIH increased both RSNA and oxidative stress. This response was attenuated by treatment of the rats with GKT137831 or NAC. Inhibiting Nox4 activity or ROS production reduced RhoA/ROCK expression. Treatment with Y27632 reduced both BP and RSNA in rats exposed to CIH.

Conclusion

Hypertension can be induced by CIH in SD rats. The CIH-induced elevation of BP is at least partially mediated via the Nox4-induced ROS/RhoA/ROCK pathway.
Literatur
1.
Mooe T, Franklin KA, Wiklund U, Rabben T, Holmstrom K (2000) Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest 117:1597–1602CrossRefPubMed
2.
3.
Prabhakar NR, Kumar GK (2010) Mechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxia. Respir Physiol Neurobiol 174:156–161CrossRefPubMedPubMedCentral
4.
Xing T, Pilowsky PM, Fong AY (2014) Mechanism of sympathetic activation and blood pressure elevation in humans and animals following acute intermittent hypoxia. Prog Brain Res 209:131–146CrossRefPubMed
5.
Peng YJ, Yuan G, Khan S, Nanduri J, Makarenko VV, Reddy VD et al (2014) Regulation of hypoxia-inducible factor-alpha isoforms and redox state by carotid body neural activity in rats. J Physiol 592:3841–3858CrossRefPubMedPubMedCentral
6.
Prabhakar NR, Peng YJ, Kumar GK, Nanduri J (2015) Peripheral chemoreception and arterial pressure responses to intermittent hypoxia. Compr Physiol 5:561–577CrossRefPubMedPubMedCentral
7.
Eckardt KU, Bernhardt WM, Weidemann A, Warnecke C, Rosenberger C, Wiesener MS, et al. (2005) Role of hypoxia in the pathogenesis of renal disease. Kidney Int SupplS46-S51
8.
Loirand G, Pacaud P (2010) The role of Rho protein signaling in hypertension. Nat Rev Cardiol 7:637–647CrossRefPubMed
9.
Nguyen DCA, Touyz RM (2011) Cell signaling of angiotensin II on vascular tone: novel mechanisms. Curr Hypertens Rep 13:122–128CrossRef
10.
11.
Mukai Y, Shimokawa H, Matoba T, Kandabashi T, Satoh S, Hiroki J et al (2001) Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J 15:1062–1064PubMed
12.
Moriki N, Ito M, Seko T, Kureishi Y, Okamoto R, Nakakuki T et al (2004) RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertens Res 27:263–270CrossRefPubMed
13.
Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A (2001) Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 38:1307–1310CrossRefPubMed
14.
Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T et al (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990–994CrossRefPubMed
15.
16.
Dumitrascu R, Heitmann J, Seeger W, Weissmann N, Schulz R (2013) Obstructive sleep apnea, oxidative stress and cardiovascular disease: lessons from animal studies. Oxidative Med Cell Longev 2013:234631CrossRef
17.
Harrison DG, Gongora MC (2009) Oxidative stress and hypertension. Med Clin North Am 93:621–635CrossRefPubMed
18.
O’Halloran KD (2015) Chronic intermittent hypoxia creates the perfect storm with calamitous consequences for respiratory control. Respir Physiol Neurobiol
19.
Rubattu S, Pagliaro B, Pierelli G, Santolamazza C, Castro SD, Mennuni S et al (2015) Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress. Int J Mol Sci 16:823–839CrossRef
20.
Denniss SG, Jeffery AJ, Rush JW (2010) RhoA-Rho kinase signaling mediates endothelium- and endoperoxide-dependent contractile activities characteristic of hypertensive vascular dysfunction. Am J Physiol Heart Circ Physiol 298:H1391–H1405CrossRefPubMed
21.
Schluter T, Steinbach AC, Steffen A, Rettig R, Grisk O (2008) Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition. Cardiovasc Res 80:271–279CrossRefPubMed
22.
Sun Q, Yue P, Ying Z, Cardounel AJ, Brook RD, Devlin R et al (2008) Air pollution exposure potentiates hypertension through reactive oxygen species-mediated activation of Rho/ROCK. Arterioscler Thromb Vasc Biol 28:1760–1766CrossRefPubMedPubMedCentral
23.
Jin L, Ying Z, Webb RC (2004) Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol 287:H1495–H1500CrossRefPubMed
24.
Feng SZ, Tian JL, Zhang Q, Wang H, Sun N, Zhang Y et al (2011) An experimental research on chronic intermittent hypoxia leading to liver injury. Sleep Breath 15:493–502CrossRefPubMed
25.
Idiaquez J, Santos I, Santin J, Del RR, Iturriaga R (2014) Neurobehavioral and autonomic alterations in adults with obstructive sleep apnea. Sleep Med 15:1319–1323CrossRefPubMed
26.
Iturriaga R, Andrade DC, Del RR (2014) Enhanced carotid body chemosensory activity and the cardiovascular alterations induced by intermittent hypoxia. Front Physiol 5:468CrossRefPubMedPubMedCentral
27.
Marcus JA, Pothineni A, Marcus CZ, Bisognano JD (2014) The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension. Curr Hypertens Rep 16:411CrossRefPubMed
28.
29.
Levy P, Tamisier R, Arnaud C, Monneret D, Baguet JP, Stanke-Labesque F et al (2012) Sleep deprivation, sleep apnea and cardiovascular diseases. Front Biosci (Elite Ed) 4:2007–2021
30.
Del RR, Moya EA, Parga MJ, Madrid C, Iturriaga R (2012) Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia. Eur Respir J 39:1492–1500CrossRef
31.
Peng YJ, Raghuraman G, Khan SA, Kumar GK (1985) Prabhakar NR (2011) angiotensin II evokes sensory long-term facilitation of the carotid body via NADPH oxidase. J Appl Physiol 111:964–970CrossRef
32.
Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R et al (2013) Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 41:523–538CrossRefPubMed
33.
Silva AQ, Schreihofer AM (2011) Altered sympathetic reflexes and vascular reactivity in rats after exposure to chronic intermittent hypoxia. J Physiol 589:1463–1476CrossRefPubMedPubMedCentral
34.
Denton KM, Shweta A, Anderson WP (2002) Preglomerular and postglomerular resistance responses to different levels of sympathetic activation by hypoxia. J Am Soc Nephrol 13:27–34PubMed
35.
Linz D, Mahfoud F, Linz B, Hohl M, Schirmer SH, Wirth KJ et al (2014) Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea. Am J Hypertens 27:1293–1300CrossRefPubMed
36.
Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K et al (2012) Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension 60:172–178CrossRefPubMed
37.
Bao G, Metreveli N, Li R, Taylor A (1985) Fletcher EC (1997) blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 83:95–101
38.
Fletcher EC, Bao G, Li R (1999) Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34:309–314CrossRefPubMed
39.
Huang J, Lusina S, Xie T, Ji E, Xiang S, Liu Y et al (2009) Sympathetic response to chemostimulation in conscious rats exposed to chronic intermittent hypoxia. Respir Physiol Neurobiol 166:102–106CrossRefPubMed
40.
Somlyo AP, Somlyo AV (2004) Signal transduction through the RhoA/Rho-kinase pathway in smooth muscle. J Muscle Res Cell Motil 25:613–615CrossRefPubMed
41.
42.
Urena J, Lopez-Barneo J (2012) Metabotropic regulation of RhoA/Rho-associated kinase by L-type Ca2+ channels. Trends Cardiovasc Med 22:155–160CrossRefPubMed
43.
Firth AL, Choi IW, Park WS (2012) Animal models of pulmonary hypertension: Rho kinase inhibition. Prog Biophys Mol Biol 109:67–75CrossRefPubMed
44.
Lee TM, Chung TH, Lin SZ, Chang NC (2014) Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats. J Hypertens 32:795–805CrossRefPubMed
45.
de Frutos S, Caldwell E, Nitta CH, Kanagy NL, Wang J, Wang W et al (2010) NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice. Am J Physiol Heart Circ Physiol 299:H356–H363CrossRefPubMedPubMedCentral
46.
Allahdadi KJ, Walker BR, Kanagy NL (2007) ROK contribution to endothelin-mediated contraction in aorta and mesenteric arteries following intermittent hypoxia/hypercapnia in rats. Am J Physiol Heart Circ Physiol 293:H2911–H2918CrossRefPubMed
47.
Ito K, Hirooka Y, Kimura Y, Shimokawa H, Takeshita A (2005) Effects of hydroxyfasudil administered to the nucleus tractus solitarii on blood pressure and heart rate in spontaneously hypertensive rats. Clin Exp Hypertens 27:269–277CrossRefPubMed
48.
Ito K, Hirooka Y, Kishi T, Kimura Y, Kaibuchi K, Shimokawa H et al (2004) Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition. Hypertension 43:156–162CrossRefPubMed
49.
Ito K, Hirooka Y, Sakai K, Kishi T, Kaibuchi K, Shimokawa H et al (2003) Rho/Rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nervous system: possible involvement in neural mechanisms of hypertension. Circ Res 92:1337–1343CrossRefPubMed
50.
Cui Q, Zhang Y, Chen H, Li J (2013) Rho kinase: a new target for treatment of cerebral ischemia/reperfusion injury. Neural Regen Res 8:1180–1189PubMedPubMedCentral
51.
Noma K, Kihara Y, Higashi Y (2012) Striking crosstalk of ROCK signaling with endothelial function. J Cardiol 60:1–6CrossRefPubMed
52.
Sari AN, Kacan M, Unsal D, Sahan FS, Kemal BC, Vezir O et al (2014) Contribution of RhoA/Rho-kinase/MEK1/ERK1/2/iNOS pathway to ischemia/reperfusion-induced oxidative/nitrosative stress and inflammation leading to distant and target organ injury in rats. Eur J Pharmacol 723:234–245CrossRefPubMed
53.
Satoh K, Fukumoto Y, Shimokawa H (2011) Rho-kinase: important new therapeutic target in cardiovascular diseases. Am J Physiol Heart Circ Physiol 301:H287–H296CrossRefPubMed
54.
Shi J, Wei L (2013) Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil. J Cardiovasc Pharmacol 62:341–354CrossRefPubMed
55.
Lassegue B, San MA, Griendling KK (2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 110:1364–1390CrossRefPubMedPubMedCentral
56.
Selemidis S, Sobey CG, Wingler K, Schmidt HH, Drummond GR (2008) NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 120:254–291CrossRefPubMed
57.
Gorin Y, Block K (2013) Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? Free Radic Biol Med 61:130–142CrossRefPubMed
58.
Gorin Y, Wauquier F (2015) Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease. Mol Cells 38:285–296PubMedPubMedCentral
59.
Lassegue B, Griendling KK (2010) NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 30:653–661CrossRefPubMed
60.
61.
Eid AA, Lee DY, Roman LJ, Khazim K, Gorin Y (2013) Sestrin 2 and AMPK connect hyperglycemia to Nox4-dependent endothelial nitric oxide synthase uncoupling and matrix protein expression. Mol Cell Biol 33:3439–3460CrossRefPubMedPubMedCentral
62.
Cuevas S, Zhang Y, Yang Y, Escano C, Asico L, Jones JE et al (2012) Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension 59:446–452CrossRefPubMedPubMedCentral
63.
Jha JC, Gray SP, Barit D, Okabe J, El-Osta A, Namikoshi T et al (2014) Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol 25:1237–1254CrossRefPubMedPubMedCentral
64.
Chi AY, Waypa GB, Mungai PT, Schumacker PT (2010) Prolonged hypoxia increases ROS signaling and RhoA activation in pulmonary artery smooth muscle and endothelial cells. Antioxid Redox Signal 12:603–610CrossRefPubMedPubMedCentral
65.
Knock GA, Snetkov VA, Shaifta Y, Connolly M, Drndarski S, Noah A et al (2009) Superoxide constricts rat pulmonary arteries via rho-kinase-mediated Ca(2+) sensitization. Free Radic Biol Med 46:633–642CrossRefPubMed
66.
Jackson EK, Gillespie DG, Zhu C, Ren J, Zacharia LC, Mi Z (2008) Alpha2-adrenoceptors enhance angiotensin II-induced renal vasoconstriction: role for NADPH oxidase and RhoA. Hypertension 51:719–726CrossRefPubMed
67.
Gorin Y, Cavaglieri RC, Khazim K, Lee DY, Bruno F, Thakur S et al (2015) Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes. Am J Physiol Renal Physiol 308:F1276–F1287CrossRefPubMedPubMedCentral
Metadaten
Titel
The role of the Nox4-derived ROS-mediated RhoA/Rho kinase pathway in rat hypertension induced by chronic intermittent hypoxia
verfasst von
Wen Lu
Jing Kang
Ke Hu
Si Tang
Xiufang Zhou
Lifang Xu
Yuanyuan Li
Shuhui Yu
Publikationsdatum
11.01.2017
Verlag
Springer International Publishing
Erschienen in
Sleep and Breathing / Ausgabe 3/2017
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-016-1449-2

Weitere Artikel der Ausgabe 3/2017

Sleep and Breathing 3/2017 Zur Ausgabe

Sleep Breathing Physiology and Disorders • Original Article

Changes in lower incisor irregularity during treatment with oral sleep apnea appliances

Sleep Breathing Physiology and Disorders • Original Article

Is obstructive sleep apnea associated with the presence of intracranial cerebral atherosclerosis?

Sleep Breathing Physiology and Disorders • Original Article

Utility of home sleep apnea testing in high-risk veterans

Sleep Breathing Physiology and Disorders • Review

The effect of intermittent fasting during Ramadan on sleep, sleepiness, cognitive function, and circadian rhythm

Dentistry • Original Article

The long-term effects of mandibular advancement splint on cardiovascular fitness and psychomotor performance in patients with mild to moderate obstructive sleep apnea: a prospective study

Sleep Breathing Physiology and Disorders • Short Communication

Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apnea

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 | NSCLC | Nachrichten

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise